EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 (Mars 2007) Hors série n° 1 Med Sci (Paris), 23 (2007) 27-30 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Mars 2007
Protéomique clinique en oncologie
Page(s) 27 - 30
Section M/S revues
DOI https://doi.org/10.1051/medsci/2007231s27
Published online 15 March 2007
  1. Hondermarck, H. (ed) (2004) Biomedical and Pharmaceutical Applications of Proteomics, Kluwer-Springer, Dordrecht, The Netherlands.ISBN: 1-4020-23 22–7. [Google Scholar]
  2. Hondermarck H. Breast cancer: when proteomics challenges biological complexity. Mol Cell. Proteomics 2003; 2 : 281–91. [Google Scholar]
  3. Celis JE, Moreira JM, Gromova I, et al. Towards discovery-driven translational research in breast cancer. FEBS J 2005; 272 : 2–15 [Google Scholar]
  4. Vercoutter-Edouart AS, Lemoine J, Le Bourhis X, et al. Proteomic analysis reveals that 14-3-3 sigma is down-regulated in human breast cancer cells. Cancer Res 2001; 61 : 76–80 [Google Scholar]
  5. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003;3 : 931–43 [Google Scholar]
  6. Descamps S, Toillon RA, Adriaenssens E, et al. Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem 2001;276 : 17864–70. [Google Scholar]
  7. Dollé L, El-Yazidi I, Adriaenssens E, et al. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene 2003; 22 : 5592–601. [Google Scholar]
  8. Dolle L, Adriaenssens E, El Yazidi-Belkoura I, et al. Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets 2004;4 : 463–70 [Google Scholar]
  9. Aebersold R, Mann M. Mass spectrometry-based proteomics. Nature 2003; 422 : 198–207. [Google Scholar]
  10. Jensen ON. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. Curr Opin Chem Biol 2004; 8 : 33–41. [Google Scholar]
  11. Vandermoere F, El Yazidi-Belkoura I, Adriaenssens E, et al. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 2005;24 : 5482–91. [Google Scholar]
  12. Vandermoere F, El Yazidi-Belkoura I, Slomianny C, et al. The valosin containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem 2006; 281 : 14307–13. [Google Scholar]
  13. Vandermoere F, El-Yaridi-Belkoura I, Demont Y, et al. Proteomic exploration reveals that actin is a signaling target of the kinase Akt. Mol Cell Proteomics 2007; 6 : 114–24. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.